// App-Quantinova.ai

SAT-036 : Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study

Researchers

Presenter

  • Charmian A Quigley

Principal Investigators

  • Alan G Zimmermann

  • Cheri L Deal

  • Judith L. Ross

  • Ron G Rosenfeld

  • Gordon B Cutler

  • Werner F Blum

Medical Centers

  • University of Giessen, Giessen, Germany

  • Thomas Jefferson University duPont Hospital for Children, Philadelphia, PA

  • Sydney Adventist Hospital, Sydney, Australia

  • Oregon Health and Science University, Portland, OR

  • Sainte-Justine Hospital, Montreal, QC, Canada

Locations

  • United States

  • Germany

  • Canada

  • Australia

Companies

  • Cutler Consulting LL

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Short stature, idiopathic, X-linked

  • Precocious puberty

  • Type 1 diabetes mellitus

  • Hypothyroidism

  • Isolated short stature

  • Diabetes

  • Attention deficit hyperactivity disorder

Biomarkers

  • Growth Hormone 1

  • Body mass index

Drug/Treatment

  • hGH

  • Sandolase

Outcome

  • N/A

Study Design

  • observational

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved